• Return to Headlines

Shares of CR Bard Has Risen Above Previous 52-Week High

By Nick Russo

Shares of CR Bard (NYSE:BCR) traded at a new 52-week high today of $311.02. This new high was reached on below average trading volume as 156,000 shares traded hands, while the average 30-day volume is approximately 460,000 shares.

C. R. Bard, Inc. designs, manufactures, packages, distributes, and sells medical, surgical, diagnostic, and patient care devices. The Company sells a broad range of products worldwide to hospitals, individual healthcare professionals, extended care facilities and alternate site facilities. Bard markets vascular, urological, oncological, and surgical specialties products.

In the past 52 weeks, CR Bard share prices have been bracketed by a low of $166.29 and a high of $311.02 and are now at $310.93, 87% above that low price. Over the last five market days, the 200-day moving average (MA) has gone up 0.4% while the 50-day MA has advanced 0.9%.

CR Bard (NYSE:BCR) is currently priced 19.9% above its average consensus analyst price target of $249.13. CR Bard shares have support at the 50-day moving average (MA) of $202.16 and additional support at the 200-day MA of $191.81.

SmarTrend recommended that subscribers consider buying shares of CR Bard on December 23rd, 2016 as our proprietary SmarTrend analytics indicated a new Uptrend was in progress when shares hit $222.45. Since that recommendation, shares of CR Bard have risen 39.4%. We continue to monitor BCR for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.

Keywords: 52 week high/lows cr bard

Ticker(s): BCR